<?xml version="1.0" encoding="UTF-8"?>
<ref id="b31-1031825">
 <label>31.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hehlmann</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Lauseker</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Saussele</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants</article-title>. 
  <source>Leukemia</source>. 
  <year>2017</year>;
  <volume>31</volume>(
  <issue>11</issue>):
  <fpage>2398</fpage>â€“
  <lpage>2406</lpage>.
  <pub-id pub-id-type="pmid">28804124</pub-id>
 </mixed-citation>
</ref>
